Type I interferon dysregulation drives distinct pathogenic pathways in early- and late-onset lupus nephritis
Early-onset LN is characterized by elevated type I IFN activity and neutrophil-driven inflammation, reflecting a more aggressive phenotype. These findings highlight the potential therapeutic targets and emphasize the importance of personalized treatment. Early modulation of type I IFN may prevent fibrosis and improve renal outcomes in early-onset LN.
Authors
- Atsushi Kawakami (ORCID: https://orcid.org/0000-0001-9461-6372)
- Hiroko Hagiwara
- Kunihiro Ichinose (ORCID: https://orcid.org/0000-0001-8794-7106)
- Mineaki Kitamura (ORCID: https://orcid.org/0000-0002-0003-8645)
- Tomoya Nishino (ORCID: https://orcid.org/0000-0002-6270-3655)
Institutions
- University of Nagasaki (JP)
- Shimane University (JP)
- Nagasaki University (JP)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1093/rheumatology/keaf211
- Citations
- 3
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 5.00